INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -66.7% | 1,727 | +5.3% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,640 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,640 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 1,640 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -80.6% | 1,640 | -78.2% | 0.00% | – |
| Q4 2021 | $31,000 | -70.5% | 7,520 | -48.6% | 0.00% | -100.0% |
| Q3 2021 | $105,000 | -22.8% | 14,640 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $136,000 | +580.0% | 14,640 | +584.1% | 0.00% | – |
| Q1 2021 | $20,000 | -68.3% | 2,140 | -70.1% | 0.00% | – |
| Q4 2020 | $63,000 | -47.1% | 7,165 | -29.9% | 0.00% | -100.0% |
| Q3 2020 | $119,000 | -69.7% | 10,221 | -29.9% | 0.00% | -75.0% |
| Q2 2020 | $393,000 | +4812.5% | 14,573 | +1189.6% | 0.00% | – |
| Q1 2020 | $8,000 | -91.4% | 1,130 | -92.3% | 0.00% | -100.0% |
| Q3 2017 | $93,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |